Editorial Commentary: Colistin and a New Paradigm in Drug Development.

Van Bambeke, Françoise; Tulkens, Paul M.

doi:10.1093/cid/civ968

Editorial Commentary: Colistin and a New Paradigm in Drug Development.

Van Bambeke, Françoise

;

Tulkens, Paul M.

(2016) Clinical Infectious Diseases — Vol. 62, n° 5, p. 559-560 (2016)

Files

2016-ClinInfectDis_VanBambeke.pdf

Restricted Access
Adobe PDF
109.19 KB

Request a copy

Details

Authors

Van Bambeke, FrançoiseUCLouvain
Author
Tulkens, Paul M.UCLouvain
Author

Affiliations

UCLouvainSSS/LDRI - Louvain Drug Research Institute

Citations

APA
Chicago
FWB

Van Bambeke, F., & Tulkens, P. M. (2016). Editorial Commentary: Colistin and a New Paradigm in Drug Development. Clinical Infectious Diseases, 62(5), 559-560. https://doi.org/10.1093/cid/civ968 (Original work published 2016)